Cargando…
Central nervous system tumefactive demyelinating lesions: Risk factors of relapse and follow-up observations
OBJECTIVE: To track the clinical outcomes in patients who initially presented with tumefactive demyelinating lesions (TDLs), we summarized the clinical characteristics of various etiologies, and identified possible relapse risk factors for TDLs. METHODS: Between 2001 and 2021, 116 patients initially...
Autores principales: | Li, Xinnan, Miao, Xiuling, Wang, Yaming, Sun, Junzhao, Gao, Haifeng, Han, Jing, Li, Yuxin, Wang, Qingjun, Sun, Chenjing, Liu, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752826/ https://www.ncbi.nlm.nih.gov/pubmed/36532021 http://dx.doi.org/10.3389/fimmu.2022.1052678 |
Ejemplares similares
-
Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma
por: Sun, Chenjing, et al.
Publicado: (2022) -
Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Publicado: (2017) -
Corrigendum: Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Publicado: (2017) -
A Case of Relapsing-Remitting Tumefactive Demyelination
por: Wadhwa, Ankur, et al.
Publicado: (2019) -
The value of convolutional neural networks-based deep learning model in differential diagnosis of space-occupying brain diseases
por: Miao, Xiuling, et al.
Publicado: (2023)